| Date | Issuer | Type | Security | Price | Units | Value | |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc. | S | Common Stock, $0.0001 par value per share | |||||
| LB Pharmaceuticals Inc | C | Common Stock | |||||
| LB Pharmaceuticals Inc | C | Series C Preferred Stock | |||||
| LB Pharmaceuticals Inc | P | Common Stock | |||||
| LB Pharmaceuticals Inc | A | Stock Option (Right to Buy) |